Andrew Avery
Sports Medicine · Detroit, MINPI 1255587945
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 165 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 31 manufacturers, the largest accounting for just 13.6% — the pattern of someone who eats at a lot of different presentations.
Across 165 payments — averaging $30.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$690
- AbbVie$662
- GSK$429
- Teva Pharmaceuticals USA, Inc.$383
- Abbott$300
- Lilly USA, LLC$279
- plus $2K from 25 others
What the payments were for
- Food & beverage$5,077100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 11 | $690 |
| AbbVie(2 entities) | 26 | $662 |
| GSK | 21 | $429 |
| Teva Pharmaceuticals USA, Inc. | 6 | $383 |
| Abbott | 3 | $300 |
| Lilly USA, LLC | 17 | $279 |
| Pfizer | 18 | $234 |
| Otsuka America Pharmaceutical, Inc. | 9 | $216 |
| Boston Scientific | 4 | $214 |
| Alnylam Pharmaceuticals Inc. | 5 | $182 |
| Amarin Pharma, Inc. | 1 | $145 |
| Bayer | 1 | $136 |
| Novartis | 3 | $134 |
| Aimmune Therapeutics, Inc. | 1 | $125 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 5 | $115 |
| Abiomed | 2 | $113 |
| Sanofi Pasteur Inc. | 1 | $111 |
| Exact Sciences | 6 | $110 |
| Sanofi-aventis U.S. LLC | 6 | $94 |
| Novo Nordisk | 6 | $91 |
| Amgen | 1 | $81 |
| Biohaven Pharmaceuticals, Inc. | 3 | $43 |
| Dexcom, Inc. | 1 | $27 |
| Axsome Therapeutics, Inc. | 1 | $25 |
| Phathom Pharmaceuticals, Inc. | 1 | $24 |
| Merck | 1 | $24 |
| Sequel Med Tech, LLC | 1 | $19 |
| Gilead | 1 | $19 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $18 |
| Shield Therapeutics Inc | 1 | $18 |
| Boehringer Ingelheim | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,077 in reported general payments places this provider in the 75th percentile of 145 sports medicine providers in Michigan.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Omeprazole-Sodium BicarbonateOmeprazole/Sodium Bicarbonate | 79 | $267,130 |
| Famotidine | 403 | $95,485 |
| Diclofenac Potassium | 32 | $72,904 |
| Chlorzoxazone | 75 | $66,214 |
| Diclofenac Sodium | 171 | $63,925 |
| JardianceEmpagliflozin | 60 | $44,000 |
| JanuviaSitagliptin Phosphate | 20 | $18,236 |
| Tizanidine Hcl | 56 | $18,160 |
| TrulicityDulaglutide | 13 | $17,061 |
| Acetaminophen-CodeineAcetaminophen With Codeine | 618 | $16,854 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 61 | $15,449 |
| Metformin Hcl | 110 | $12,562 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 343 | $10,940 |
| Cyclobenzaprine Hcl | 105 | $9,764 |
| Celecoxib | 105 | $9,565 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimJardiance | $17 | $44,00060 claims |
| GSKBreo Ellipta, Trelegy Ellipta, Incruse Ellipta | $429 | $20,26245 claims |
| MerckJanuvia | $24 | $18,23620 claims |
| Lilly USA, LLCTrulicity | $279 | $17,06113 claims |
| PfizerEliquis | $234 | $7,94212 claims |
| Sanofi-aventis U.S. LLCAdmelog, Lantus | $94 | $3,12634 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 145 sports medicine providers in Michigan.
Other sports medicine in Detroit
- Vasilios MoutzourosDetroit$40K
- Eric MakhniDetroit$19K
- Michael JawadDetroit$9K
- Joshua GatzDetroit$7K
- Brian RillDetroit$3K
- Moustafa BazziDetroit$3K
- Tariq AwanFarmington Hills$113K
- Michael YusafAuburn Hills$101K
- Jack PinneyMidland$67K
- William KestoNovi$62K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.